ACARBOSE TABLETS
As listed in the register: ACARBOSE TABLETS
50 mg · tablet
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Acarbose
- Made by
- Strides Pharma Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Acarbose). It describes the substance, not this exact product.
In contrast to sulfonylureas, Acarbose Tablets do not enhance insulin secretion.
The antihyperglycemic action of acarbose results from a competitive, reversible inhibition of pancreatic alpha-amylase and membrane-bound intestinal alpha-glucoside hydrolase enzymes.
Acarbose is metabolized exclusively within the gastrointestinal tract, principally by intestinal bacteria, but also by digestive enzymes.
An average of 51% of an oral dose was excreted in the feces as unabsorbed drug-related radioactivity within 96 hours of ingestion.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-11
Safety of the active substance
From the US prescribing label for the same active substance (Acarbose). It describes the substance, not this exact product.
- Acarbose Tablets are contraindicated in patients with known hypersensitivity to the drug.
- Acarbose Tablets are also contraindicated in patients with inflammatory bowel disease, colonic ulceration, partial intestinal obstruction or in patients predisposed to intestinal obstruction.
- In addition, Acarbose Tablets are contraindicated in patients who have chronic intestinal diseases associated with marked disorders of digestion or absorption and in patients who have conditions that may deteriorate as a result of increased gas formation in the intestine.
The most common reactions to Acarbose Tablets.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Spain6 matching products
Details
| Made by | Strides Pharma Canada Inc |
|---|---|
| Active substance | Acarbose |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 50 mg |
| Form | tablet |
| Classification | A10BF01 · Digestion, stomach, diabetes and nutrition |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02493780 |
| DPD drug code | 98378 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 50 mg
- 100 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.